SCHEMBL18175860

SCHEMBL18175860

C=c1cccc/c1=C/C=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20444009 0.77
SCHEMBL24800752 0.77 TRPA1 (0.30)
SCHEMBL22569505 0.77
SCHEMBL20215593 0.77
SCHEMBL18909699 0.76
SCHEMBL19234845 0.75
SCHEMBL21312918 0.75 MEN1 (0.36)
SCHEMBL13911582 0.74
SCHEMBL20076854 0.73 ALDH1A1 (0.32)
SCHEMBL22015754 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025942-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. 2024-01-25 US disclosed
US-20230287037-A1 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. 2023-09-14 US disclosed
US-20230270657-A1 Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and Method PROVECTUS PHARMATECH, INC. (US) 2023-08-31 US disclosed
US-20230054084-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2023-02-23 US disclosed
US-20220002340-A1 C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE SAGE THERAPEUTICS INC (US) 2022-01-06 US disclosed
US-20210347812-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. 2021-11-11 US disclosed
US-20210040141-A1 3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. 2021-02-11 US disclosed
US-20210033969-A1 CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-02-04 US disclosed
US-10836725-B2 Modulators of the integrated stress pathway ABBVIE INC. (US) 2020-11-17 US disclosed
US-20200306262-A1 COMPOUNDS AND METHODS OF THEIR USE SAGE THERAPEUTICS INC (US) 2020-10-01 US disclosed
US-20190194135-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC 2019-06-27 US disclosed
US-10206907-B2 Compounds useful for the treatment of degenerative and inflammatory diseases GALAPAGOS NV (BE) 2019-02-19 US disclosed
US-20170129837-A1 VINYLBENZYLATED PHENOL COMPOUND, METHOD OF MANUFACTURING VINYLBENZYLATED PHENOL COMPOUND, ACTIVATED ESTER RESIN, METHOD OF MANUFACTURING ACTIVATED ESTER RESIN, THERMOSET RESIN COMPOSITION, HARDENED MATERIAL OF THERMOSET RESIN COMPOSITION, INTERLAYER INSULATING MATERIAL, PREPREG, AND METHOD OF MANUFACTURING PREPREG AIR WATER INC. (JP) 2017-05-11 US disclosed
US-20170035738-A1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES ALFASIGMA S.P.A. (IT) 2017-02-09 US disclosed
EP-2589625-B1 THERMOSETTING RESIN COMPOSITION, CURED PRODUCT THEREOF, ACTIVE ESTER RESIN, SEMICONDUCTOR SEALING MATERIAL, PREPREG, PRINTED CIRCUIT BOARD, AND BUILD-UP FILM DAINIPPON INK & CHEMICALS (JP) 2016-10-26 EP disclosed